Specialist pharmaceutical digital marketing agency

It depends on the medicine. Prescription-only medicines cannot be advertised to the public at all; some pharmacy and general-sale medicines can be, within the MHRA rules and the advertising codes. Consumer activity for POM brands focuses on compliant disease awareness and information. A specialist pharma digital marketing agency plans within those lines from the start.

A pharmaceutical digital marketing agency specialises in growing pharma and life-sciences brands within the MHRA rules, the ABPI Code and the PMCPA. It covers SEO, PPC, content, link building, digital PR, social and GEO, all planned so campaigns clear compliance before they go live.

Because in pharma, one wrong audience match is all it takes. A campaign meant for healthcare professionals that leaks into public view, or a claim that’s fine for a POM aimed at prescribers but not for the public, can trigger a PMCPA complaint before you’ve even seen the results. A generalist agency finds these lines by crossing them. We start knowing exactly where they are.

Materials aimed at healthcare professionals and materials aimed at the public are governed by different rules. We plan content, targeting and gating so the right information reaches the right audience within the ABPI Code and MHRA requirements.

Whichever discipline you need, SEO, PPC, digital PR or GEO, the same question gets asked first: would this survive an MHRA or ABPI review? Engage one on its own, or run all multiple services as an integrated campaign; either way, the answer has to be yes before anything goes live.

The MHRA oversees medicines advertising, prescription-only medicines may not be advertised to the public, and over-the-counter promotion follows the PAGB codes. Communication to healthcare professionals sits under the ABPI code, which is why audience separation matters so much here.

For pharmacy and OTC products, generally yes with certification, and Google requires online pharmacies to be verified in the markets they target. Prescription-only medicine advertising to the public remains off limits regardless of platform permissions.

With genuine gating and separate content estates rather than a disclaimer nobody reads: distinct sections, access controls where required, and messaging written for one audience only. A page that tries to serve both is the fastest route to a compliance finding.

Public-facing content that names a prescription-only product, efficacy claims beyond the licensed indication, and professional material reachable without gating. Search makes the third far easier to get wrong, because indexation does not respect an intended audience.

Yes, and carefully. Assistants paraphrase, so a page that leaves the licensed indication or the audience implied can be summarised inaccurately. We write regulated facts explicitly for that reason with our GEO service.

By writing to the code and referencing sources in the draft, so a reviewer verifies rather than rewrites. Where a claim rests on the licence or published evidence, that reference sits alongside it instead of being requested afterwards.

Yes, PostMyMeds is a strong example: an online pharmacy competing in a market that’s both tightly regulated and fiercely contested for visibility. As with all our case studies, every figure states its basis, and reported numbers are kept clearly separate from anything derived or estimated.